Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
TSHA
Stock Latest News
Ratings
Positive Outlook for Taysha Gene Therapies: Buy Rating Reinforced by Strong Financial Position and Promising Clinical Progress
16d ago
TSHA
Premium
The Fly
Taysha Gene Therapies price target raised to $14 from $11 at Canaccord
16d ago
TSHA
Premium
Company Announcements
Taysha Gene Therapies Advances Rett Syndrome Trials
16d ago
TSHA
Premium
The Fly
Taysha Gene Therapies price target raised to $10 from $9 at Chardan
16d ago
TSHA
Premium
Ratings
Taysha Gene Therapies: Positive Outlook with Pivotal Study and Strong Financial Health Justifies Buy Rating
16d ago
TSHA
Premium
The Fly
Taysha Gene Therapies reports Q2 EPS (9c), consensus (8c)
17d ago
TSHA
Premium
Pre-Earnings
TSHA Earnings this Week: How Will it Perform?
19d ago
TSHA
Premium
The Fly
Vinay Prasad returns to FDA as head of CBER
20d ago
CAPR
MGTX
Premium
The Fly
Taysha Gene Therapies initiated with a Buy at BofA
2M ago
ACAD
TSHA
Premium
The Fly
Taysha Gene Therapies initiated with a Buy at BofA
2M ago
TSHA
Premium
Ratings
Buy Rating for Taysha Gene Therapies: Favorable Study Design and High Responder Rate
2M ago
TSHA
Premium
The Fly
Craig-Hallum bullish on Neurogene, initiates with a Buy
2M ago
NGNE
TSHA
Premium
Ratings
Promising Potential of Taysha Gene Therapies: Buy Rating Affirmed by Maury Raycroft
3M ago
TSHA
Premium
The Fly
Taysha Gene Therapies price target raised to $13 from $7 at Cantor Fitzgerald
3M ago
TSHA
Premium
Ratings
Positive Outlook for Taysha Gene Therapies’ TSHA-102: Promising Clinical Data and Commercial Viability Justify Buy Rating
3M ago
TSHA
Premium
The Fly
Taysha Gene Therapies announces inducement grant under Nasdaq listing rule
3M ago
TSHA
Premium
The Fly
Taysha Gene Therapies announces updates from TSHA-102 clinical program
3M ago
TSHA
Premium
Company Announcements
Taysha Gene Therapies Approves Share Increase Amendment
3M ago
8K
TSHA
Premium
The Fly
Taysha Gene Therapies price target raised to $11 from $9 at Canaccord
3M ago
TSHA
Premium
The Fly
Needham healthcare analyst holds analyst/industry conference call
3M ago
TSHA
Premium
The Fly
Taysha Gene Therapies price target raised to $8 from $6 at Needham
3M ago
TSHA
Premium
Ratings
Positive Outlook for Taysha Gene Therapies: Buy Rating on Promising TSHA-102 Advancements
3M ago
TSHA
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
